Business Numinus uplists to OTCQX Best Market Stock will start trading at market open Thursday under the symbol NUMIF Natalia Buendia CalvilloJanuary 26, 2022
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Canada Numinus set to open Canada’s first psychedelics neurology centre The Vancouver based firm is acquiring the Neurology Centre of Toronto in a cash and stock deal Natalia Buendia CalvilloJuly 7, 2021